|
Norethindrone and Ethinyl Estradiol Tablets
» Norethindrone and Ethinyl Estradiol Tablets contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of norethindrone (C20H26O2), and not less than 90.0 percent and not more than 110.0 percent of the labeled amount of ethinyl estradiol (C20H24O2).
Packaging and storage
Preserve in well-closed containers.
Identification
Crush 1 Tablet in 1 mL of alcohol in a 15-mL conical centrifuge tube, and warm to 50
Dissolution
Medium:
0.09% sodium dodecyl sulfate in 0.1 N hydrochloric acid; 500 mL.
Apparatus 2:
75 rpm.
Time:
60 minutes.
Determine the amounts of norethindrone (C20H26O2) and ethinyl estradiol (C20H24O2) dissolved, employing the following method.
Mobile phase
Prepare a degassed and filtered mixture of 0.02 M pH 6.0 phosphate buffer and acetonitrile (65:35). Make adjustments if necessary (see System Suitability under Chromatography
Chromatographic system
(see Chromatography
Procedure
Separately inject equal volumes (about 100 µL) of the Standard solution and a filtered portion of the solution under test into the chromatograph, record the chromatograms, and measure the responses for the major peaks. The relative retention times are about 0.9 for norethindrone and 1.0 for ethinyl estradiol. Calculate the quantities of norethindrone (C20H26O2) and ethinyl estradiol (C20H24O2) dissolved by comparison of the corresponding peak responses obtained from the Standard solution and the solution under test.
Tolerances
Not less than 75% (Q) of each of the labeled amounts of C20H26O2 and C20H24O2, respectively, are dissolved in 60 minutes.
Uniformity of dosage units
Assay
Mobile phase
Prepare a filtered and degassed mixture of acetonitrile and water (60:40). Make adjustments if necessary (see System Suitability under Chromatography
Internal standard solution
Transfer about 15 mg of valerophenone into a 250-mL volumetric flask, add 125 mL of acetonitrile, dilute with water to volume, and mix.
Ethinyl estradiol standard stock solution
Dissolve an accurately weighed quantity of USP Ethinyl Estradiol RS in acetonitrile, and dilute quantitatively and stepwise with acetonitrile to obtain a solution having a known concentration of about 0.09 mg per mL.
Norethindrone standard stock solution
Using an accurately weighed quantity of USP Norethindrone RS, prepare a solution in acetonitrile having a known concentration of about 1.25 mg per mL.
Mixed standard preparation
Transfer 5.0 mL of Internal standard solution into a 100-mL volumetric flask. Add accurately measured volumes of Ethinyl estradiol standard stock solution and Norethindrone standard stock solution so that the final known concentrations, in mg per mL, of the Reference Standards correspond numerically to about one-twentieth of the labeled amounts of the corresponding ingredients in the Tablets. Add (26
Assay preparation
Transfer 10 Tablets to a 100-mL volumetric flask, add 20 mL of water, and shake by mechanical means until the tablets are completely disintegrated. Add 10.0 mL of Internal standard solution and 60 mL of acetonitrile, and mix. Sonicate for about 2 minutes. Dilute with acetonitrile to volume, and mix. Allow solid particles to settle, or centrifuge if necessary to obtain a slightly turbid solution. Dilute 5.0 mL of this solution with a mixture of acetonitrile and water (45 in 100) to 10.0 mL, and mix.
Chromatographic system
(see Chromatography
Procedure
Separately inject equal volumes (about 25 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. The relative retention times are about 0.9 for ethinyl estradiol and 1.0 for norethindrone. Calculate the quantities, in mg, of norethindrone (C20H26O2) and ethinyl estradiol (C20H24O2) in each Tablet taken by the formula:
20C(RU / RS)
in which C is the concentration, in mg per mL, of the appropriate USP Reference Standard in the Mixed standard preparation, and RU and RS are the peak response ratios, at corresponding retention times, obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 4076
Pharmacopeial Forum: Volume No. 33(6) Page 1194
|